SCHEDULE: Pertento Partners Discloses 4.6% Stake in Nutex Health

Pertento Partners LLP and Eduardo Marques have disclosed a 4.6% beneficial ownership stake in Nutex Health, Inc., holding 324,422 shares of common stock.

Summary

• Pertento Partners LLP and Eduardo Marques reported beneficial ownership of 324,422 shares of Nutex Health, Inc. common stock.
• This represents 4.6% of the company's outstanding common stock.
• The reporting persons share both voting and dispositive power over all 324,422 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous ownership disclosure for the period ending 12/31/2025.
• The securities are held by advisory clients of Pertento Partners LLP, with no single client beneficially owning more than 5% of the common stock.
• The reporting persons certified that the securities were not acquired for the purpose of changing or influencing control of Nutex Health, Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it signals institutional confidence in Nutex Health, Inc. without suggesting any immediate strategic shifts or activist pressure.

Positives

• A significant institutional investor, Pertento Partners LLP, and its managing partner, Eduardo Marques, have disclosed a substantial, albeit passive, stake in Nutex Health, Inc.
• The filing indicates a passive investment intent, as the stake is below the 5% threshold for active reporting and the certification explicitly states no intent to influence control.

Negatives

• The disclosed stake of 4.6% is below the 5% threshold, meaning the reporting persons are not required to file a Schedule 13D, which would indicate an intent to influence or control the issuer, thus limiting insight into their strategic intentions.

Future Outlook

NA

Management Comments

• Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

StockSavvy.ai notes that a 4.6% passive stake by an investment adviser like Pertento Partners LLP in a healthcare company like Nutex Health, Inc. suggests a belief in the company's long-term value proposition within the sector, without an immediate intent for activist engagement. This type of disclosure is common for institutional investors managing client portfolios.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may provide a degree of confidence, suggesting professional investors see value in Nutex Health.
• Management: The passive nature of the stake (below 5% and explicit disclaimer of control intent) suggests no immediate pressure or challenge to current management.

Next Steps

• The reporting persons will be required to file further amendments to Schedule 13G if their beneficial ownership percentage changes significantly (e.g., crosses the 5% threshold or drops below 0%).

Key Dates

Recommendation

This Schedule 13G filing primarily provides a factual update on a passive ownership stake by Pertento Partners LLP and Eduardo Marques. It does not contain new financial performance data, strategic announcements, or significant changes in company operations that would warrant a 'buy' or 'sell' recommendation. The 4.6% stake, while notable, is below the threshold for activist intent, suggesting a long-term, passive investment. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to alter an existing investment thesis.

Keywords

Nutex Health, NTXH, Pertento Partners, Eduardo Marques, Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, SEC filing, healthcare investment